Menu
Search
|

Menu

Close
X

China Resources Double-Crane Pharmaceutical Co Ltd 600062.SS (Shanghai Stock Exchange)

21.56 CNY
-0.17 (-0.78%)
As of Feb 14
chart
Previous Close 21.73
Open 21.69
Volume 2,386,035
3m Avg Volume 7,269,115
Today’s High 21.69
Today’s Low 21.35
52 Week High 25.58
52 Week Low 18.28
Shares Outstanding (mil) 869.36
Market Capitalization (mil) 18,752.20
Forward P/E 22.39
Dividend (Yield %) 0.08 ( 0.38 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.56 Mean rating from 9 analysts

KEY STATS

Revenue (mm, CNY)
FY17
4,756
FY16
5,495
FY15
5,847
EPS (CNY)
FY17
0.834
FY16
0.822
FY15
0.908
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
22.39
35.76
Price to Sales (TTM)
vs sector
3.07
8.59
Price to Book (MRQ)
vs sector
2.55
5.23
Price to Cash Flow (TTM)
vs sector
--
26.13
Total Debt to Equity (MRQ)
vs sector
0.04
15.32
LT Debt to Equity (MRQ)
vs sector
0.00
11.95
Return on Investment (TTM)
vs sector
12.21
13.59
Return on Equity (TTM)
vs sector
12.04
15.20

EXECUTIVE LEADERSHIP

Chuncheng Wang
Chairman of the Board, Since 2015
Salary: --
Bonus: --
Xin Li
President, Director, Since 2005
Salary: --
Bonus: --
Yanxi Fan
Vice President, Secretary of the Board, Director, Since 2012
Salary: --
Bonus: --
Xianxia Chen
Vice President, Since 2005
Salary: --
Bonus: --
Zhiyong Ge
Vice President, Since 2005
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

No.1 Li Ze East Second Road
Wangjing Area, Chaoyang District
BEIJING   BEJ   100102

Phone: +8610.64398099
Site: www.dcpc.com

CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD. is a China-based company principally engaged in the development, manufacture and distribution of pharmaceuticals. The Company's main businesses are classified into three segments: Chronic Disease segment, Specialist segment and Infusion segment. Chronic Disease segment mainly provides products for lowering blood pressure, blood fat and blood glucose. Specialist segment mainly involves in the research, development and distribution of pharmaceuticals targeting six areas, including cardiovascular and cerebrovascular, pediatrics, kidney disease, mental/nerve, anesthesia and analgesia and respiratory areas. Infusion segment various types of infusion products, such as basic infusion, therapeutic infusion and nutritional. The Company distributes its products mainly in domestic market.

SPONSORED STORIES